Answers are grounded in this paper and cite their sources.
Enzymes of the six-transmembrane epithelial antigen of the prostate (STEAP) family reduce Fe³⁺ and Cu²⁺ ions to facilitate metal-ion uptake by mammalian cells. STEAPs are highly upregulated in several types of cancer, making them potential therapeutic targets. However, the structural basis for STEAP-catalyzed electron transfer through an array of cofactors to metals at the membrane luminal side remains elusive. Here, we report cryo-electron microscopy structures of human STEAP4 in absence and presence of Fe³⁺-NTA. Domain-swapped, trimeric STEAP4 orients NADPH bound to a cytosolic domain onto axially aligned flavin-adenine dinucleotide (FAD) and a single b-type heme that cross the transmembrane-domain to enable electron transfer. Substrate binding within a positively charged ring indicates that iron gets reduced while in complex with its chelator. These molecular principles of iron reduction provide a basis for exploring STEAPs as therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Oosterheert et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: